chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the first dose on 2/16/2021, approximately 6-7 days later, I felt queasy and  the smell and taste of food was distasteful.  For two days, unable to eat anything but broth and oatmeal.  After the second dose on 3/9/21, similarly, after 6-7 days same symptoms, however, to date, they have not subsided.  Food and liquids (even water and fizzy water) tastes funny, flat.  The smell of most food is nauseating, and in the last few days I have had some explosive diarrhea, now just loose stools.  For the last 3 days have felt dizzy; not constantly, but if I move my head quickly or bend over.  I did not have covid at the time of vaccination; I have had 8 covid tests in 2021 due to medical procedures and flying.
Mom brought pt. in 7/28/11 (Thurs) and pt received MENACTRA and ADACEL. On 8/2/11 (Tues) mom return with pt. and pinpoint rash noted over body. Dr. instructed mom to give pt. OTC Loratadine during the daytime and BENADRYL at night.
Side effects include Joint aches: knees, neck wrists headache, fatigue and slight elevation in temperature. Temp at the time of injection 97.3, during side effects 99.3. Tylenol for temp. My concern is that I had COVID-19 in March of 2020 and tested positive for antibodies in October of 2020. Do I need another injection?
This spontaneous report was received from a Doctor of Pharmacy concerning a male patient who on an unknown date was vaccinated with a dose of ZOSTAVAX (dose, route and lot # not provided). The pharmacist reported that the patient was having difficulty breathing within 10 minutes of receiving the vaccine. The pharmacist stated the patient had an anaphylactic reaction. At the time of the report, the outcome of the events was unknown. Additional information is not expected.
Initial information received on 24-Jan-2019 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 15 months old patient (one of the twin) who received an expired dose of 0.5 ml of vaccine DAPTACEL (lot C5102AA and expiry date 04-Dec-2018)  via unknown route in the right thigh on 22-Jan-2019. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A). It was a case of actual medication error due to expired vaccine used. It was not reported if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Mother called on 11/15/07 stating child had 9-10 "chicken pox looking areas" on stomach, shoulder, side and neck. Did not have a temperature. Inst. mom to call MD T.C. to mom 11/16/07 x 2 message left. T.L to mom 11/17/07-Areas scabbed over mom called MD -no visit made. Mom states child is fine today
Based on additional information received on 15 June 2015, this case became medically confirmed. Initial unsolicited report received from a consumer on 03 April 2015. A 13-year-old female patient, whose medical history and concomitant medications were not reported, had received a dose of DTAP (batch number, expiry date, dose, dose number, route of administration and site of administration were not reported) in the year 2015. On an unspecified date in the year 2015 after the vaccination, the patient had experienced slight swelling of arm after the immunization. Laboratory investigations were not reported. The patient was treated with KALBITOR as needed 30 mg subcutaneously. At the time of this report, the outcome of event was unknown. Documents held by sender: none. Follow up information received form a non-health care professional on 06 May 2015. No new additional information reported. Documents held by sender: none. Follow-up information received from a physician on 15 June 2015. It was reported that patient had a history of hereditary angioedema which predisposed the patient to frequent swelling episodes that could be either spontaneous or related to minor trauma. Kalbitor was prescribed to treat acute swelling reactions. Documents held by sender: none.
On 11/3, the pt experienced discomfort in left arm following vax. Red and sore all night. 11/4 symptoms worsening, soreness, redness and swelling advancing down arm but not interfering with activities. Took aspirin. 11/5 symptoms intensifying, most swelling now between elbow and hand, not feeling well. Pt went to the ER and Keflex was prescribed. 11/6 pt is much better, swelling is down. 11/7, no redness or swelling only a little sore.
little trouble with taste; positive COVID test; positive COVID test; This is a spontaneous report from Pfizer-sponsored program via contactable consumer or other non hcp. A 58-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL3249), (age 58-year at the time of vaccination) via an unspecified route of administration, administered in Arm Right on 20Jan2021 14:00 as dose 1, and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 10Feb2021 14:00 as dose 2, single for COVID-19 immunization at hospital. Medical history included diabetes mellitus from 2011 to an unknown date Verbatim: Diabetes (Additional Information for Other Conditions: from 10 years), hypertension from 2011 to an unknown date (Verbatim: Blood pressure high Additional Information for Other Conditions: from 10 years). There were no concomitant medication reported. Prior vaccinations within 4 weeks was reported as none. The patient experienced positive covid test on 26Jul2021, little trouble with taste on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test was positive on 26Jul2021 (More information available (Y/N): NO), sars-cov-2 test was negative on 05Aug2021 (More information available (Y/N): NO). AE(s) following prior vaccinations were none. Description of complaint: Consumer reporting an AE/PC for the Pfizer COVID 19 vaccine; reports she has been fully vaccinated with the Pfizer COVID 19 vaccine in Jan2021 and then tested positive for COVID on 26Jul2021. The outcome of the event positive covid test was recovered on unspecified date 2021 and the event little trouble with taste was not recovered.
Woke up out of a dead sleep the next day with severe chest pains; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 33-year-old non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on Jul2021 (at the age of 33-years-old) as dose number unknown, single for COVID-19 immunisation. The medical history of the patient included systemic inflammation, nervous system disorder and seizure disorder. The patient had no known allergies. The concomitant medications of the patient were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient had been tested negative with covid-19. The patient experienced woke up out of a dead sleep the next day with severe chest pains on an unspecified date in Aug2021. The patient reported unlike any chest pain she had experienced and she no stranger to panic attacks or tightness in chest. The event lead to physician office visit. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on an unspecified date in Aug2021. Therapeutic measures were taken as a result of event that included took Xanax for 2 days with zero relief of persistent chest pains. The outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt c/o feeling cold--temp started at 100.6 and increased to 102.6 by 10:00 pm. Pt c/o nausea and then vomited before 11:30 pm. Pt also c/o HA (chronic problem that was more intense tonight) and injection site pain. Pt c/o gen back pain the evening of 6/23/2011.
pt recvd vax & 1hr p/vax exp a bright red patch @ inj site which was approx 6cm across;also exp itching;MD prescribed DPH & advil;pt recvd 2nd dose of vax 20FEB95 & exp no rxn;
Itchiness (both arms) that occured later that day on 8/29/17, swelling, hotness, and hard on both arms that occured unknown time later, bruising on left arm that occured unknown time later. Pt reported phlegm in throat that occured today (9/2/17), and pain in sternum that occured on 8/30, and headaches that occured within the hour of 8/29/17.
DIZZINESS, VITALS TAKEN, PHYSICIAN EVALUATION, VITALS RECHECKED, MONITOR, & DISCHARGE AS PATIENT FELT BETTER.  PATIENT WAS MONITORED FOR 20 MINIUTES AFTER DIZZINESS OCCURRED.
Vesicle, about 5 mm in circ with underlying, surrounding induration and erythema with outlying ecchymosis, area tender to touch and itching, vesicle intact.
Patient received HPV, ADACEL & FLUZONE right after that patient had vomiting and had seizure for 10-20 seconds.
12/4/21 Admitted to labor and delivery, tested positive for COVID   12/6/21 Her postpartum course has been unremarkable, with good ambulation, oral intake and voiding.  By mom was meeting all post partum milestones and will be discharged home.  We have reviewed our usual discharge instructions (see orders).  Discharge meds will include Ibuprofen, FeSO4 and colace3 and she will resume her usual home medications. It was recommended due to acute blood loss anemia patient continue oral iron supplements for two weeks or until instructed to discontinue by primary OB provider She will see her primary OB provider in the office in 2 weeks.
Chills, muscle aches, nausea, sick to stomach site soreness, pt said never vomited.
I have had menstrual periods and heavier bleeding since the second dose, I am now cycling every two weeks since the vaccine. Previously I had not even had spotting. They are becoming unusually intense and long
During 04/15/14 4 mo WCE O.V. Parent reported that after 02-11-14 2mo imm., pt. slept x3 hours after, then cried x4-5 hours. Parents gave TYLENOL dose and mom nursed pt. Pt. went to sleep after and no more problems on waking. No call to PCP.
Grandmother called stating the patient's arms were extremely cold the night after the vaccination. She states she noticed mottling the evening of and the day after. Patient also developed a 102 degree fever.
States that the booster dose really set it off and she got a rash/States that a man at her gym and a lady who just left her apartment have the same problem; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, Manufacturer Unknown), for COVID-19 Immunization. The following information was reported: RASH (non-serious), outcome "unknown", described as "States that the booster dose really set it off and she got a rash/States that a man at her gym and a lady who just left her apartment have the same problem".  Additional information: Caller states that she got the vaccine last February and got the second dose by 03Mar2021. She then got the booster dose in October. Caller says that she started being itchy from the moment she got the vaccine. States that with the second dose she was itchy, itchy, itchy. States that the booster dose really set it off and she got a rash. States that a man at her gym and a lady who just left her apartment have the same problem. This report is related to the man at the caller's gym. Caller states that she declines to provide further information on the man at her gym.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-202200473977 same product and event, different patient;US-PFIZER INC-202200474085 same product and event, different patient
I did experience a headache and upset stomach 1-2 days after vaccine. I did have joint swelling. All of this kicked up late January to mid February. Joint swelling in hands and general stiffness. Mid February to late February I noticed more of the cyst on my thumb and my heel with the Achilles tendonitis.
All after second injection: Fever of 100.8. Went down to 99.8 after 4 hours. Took Tylenol to help. Headache 3 hours after second dose, has not gone away. Pain at the injection site, 2 hours after, has not gone away. Chills that started 12 hours after injection. Loss of appetite after 20 hours of injection. Back pain/body aches 8 hours after injection.  Some dizziness on and off starting 20 hours after injection.  Feeling weak 20 hours after injection.
Very high fever of 103 and flu like symptoms for 24 hours following second shot.  After having a normal and regular menstrual cycle with no perimenopausal  symptoms in August, received the second dose on August 25, 2021 and have not had a menstrual period since receiving the second dose. I have no other systems that would indicate that this is a result of menopause due to my age. I am healthy, active and have no known health issues. I  do not have a history of irregular, or changes in, menstruation leading up to the complete absence of menstruation following the second vaccination shot.
Patient was given vaccination on 7/18/2005. Approximately four days ago he reports that he developed URI sx. to include a sore throat, nasal congestion and cough. On 7/27/2005 patient noted a rash developing on his upper torso in the late morning to mid afternoon. Seen at the TMC on 7/28/05 with a diffuse rash present on the upper torso to include the trunk and abdomen. Largest portion of rash is noted on the abdomen and trunk. A less prominent rash is present on the arms. Patient reports that the rash is quite pruritic. MD noted vesicles to the back of the throat. Patient placed on quarters and was started on Benadryl 25mg po for the itch.
2-12 headache,confusion,shortness of breath. 2-16 fatigue , loss of appetite, 100 degree fever. 2-24 continued symptoms. 2-28 fever 103.1. 3-5 Dr appointment sent to ER with fluid around heart, lungs, kidney failure, abnormal  EKG, dehydration, abnormal lab work. Sent to CCU for fluid removal from heart . 3-6 spent 12 days in hospital CCU and ICU. Spent next 2 months on walker unable to care for myself. Passed out several times.
No advers effect reported; either administered a third dose of M-M-R II or a dose of Proquad at over 12 years of age; either administered a third dose of M-M-R II or a dose of Proquad at over 12 years of age; This spontaneous report was received from healthcare professional and refers to a patient of unknown age (reported by the medical assistant as of being currently "college age"). The patient's concurrent conditions, medical history or concomitant drugs were not reported.  On 30-APR-2013, the patient received a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) subcutaneously (strength, dose, lot # and expiration date not reported) and a dose of varicella virus vaccine live (Oka/Merck)(VARIVAX). Later, on 30-MAY-2013, the patient received a second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) subcutaneously (strength, dose, lot # and expiration date not reported) and a second dose of varicella virus vaccine live (Oka/Merck)(VARIVAX). The medical assistant stated that for college entry, on 30-MAY-2018, the patient received either a third dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) subcutaneously (strength, dose, lot # and expiration date not reported) or a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) subctuaneously (strength, dose, lot # and expiration date not reported). Merck Sterile diluent was used as diluent for the administered vaccines. All vaccines were administered for prophylaxis. No adverse effects were reported.
Fatigue, stomach upset began in hour one, headache began by early afternoon (hour 3), fever began by late afternoon (hour 6), vomiting began in early morning (hour 16).
Initial information received on 30-Jul-2018 regarding an unsolicited valid non-serious case received from a nurse via phone. This case involves 15 Month old patient who received 0.5 ml vaccination with ADACEL (frequency once, batch number, expiry date was not reported) intramuscularly in thigh on 30 July 2018 instead of pediatric dose. Concomitant medications included ACTHIB; and PREVNAR. It was a case of actual medication error due to Inappropriate age at vaccine administration. It was unknown if any adverse event was occurred. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Chills, shivering, bad muscle aches, nausea, malaise, low energy, still ongoing for two days.
VARIVAX, MMR, PREVNAR and Flu were ordered, but PROQUAD was given instead of the MMR. Notified provider and parent of incident. Called to follow up with mother on 10/8 and patients were doing well, denies redness or swelling at vaccines sites. Denies fever or fussiness 10/8. She stated patient and his twin were fussy 10/5 & 10/6.
12 hours after injection, had sudden shivering, could not get warm, shivering and high fever and pounding headache all night. Headache persisted well into next day.  It was a miserable night about like a really bad flu.
Headache Fever, 102.8. severe heartburn. Fever, 102.8. headache. Sever heartburn.
After few weeks of the vaccine persistent headaches occurred for 2 weeks. I took all kinds of medications but didn't work. 06/01/2022 I went to the clinic they ordered MRI of my brain but they didn't find anything that should be noted for. They told me to use FLONASE. I noticed my blood pressure was elevated. 07/14/2022 I had a follow up with my doctor for something else. I noticed my blood pressure was high again. My doctor advised me to change my diet and my doctor also prescribed me losartan. Now that my blood pressure is being normalized my headaches reduced. I will be following up with my doctor on 08/04/2022.
Severe hives outbreak all over the body 4 days after second dose of Pfizer vaccine. Hives started in groin and armpit then expanded to forearms, knees, neck, eyes, hips, back, tailbone area, head, and was severe in the hands and wrists.  Also -- The evening and through the night after the second dose (given at 8:35 AM) side effects included headache, chills, fever, muscle aches.
Erythema surrounding injection site noted 1 day after administration. Fever, induration and spreading erythema on day 2. Blister formed seen in ED. Had blister unrooted. Wound culture sent. Culture results neg. Erythema and induration lessened by days 4-5. Fever, pain and irritable behavior also resolved.
chest pain, elevated WBC, pleuritic type chest pain 03/20/07-records received from facility without DC Summary, for DOS 2/26/07-C/O chest pain, pressure sensation intermittent sharp pain to anterior mid chest. Some SOB and radiation of pain down her left arm left shoulder and left hand. Some nause no vomiting no diaphoresis.  04/26/07-per med rec final DX coded was chest pain. DC Summary not dictated.
This spontaneous report was received from a physician via a field representative concerning to 3 patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were unknown. On unknown dates since the beginning of 2017, the patients were vaccinated with unspecified doses of ZOSTAVAX, subcutaneously, for prophylaxis (strength, dose, frequency, lot number and expiration date were not reported). Subsequently, on unspecified dates in 2017 (reported as about a month after each individual injection), each patient developed a mild case of shingles. The patients sought medical attention on unknown dates in 2017, however it was unknown if treatment was given for the adverse event, and if laboratory tests were performed. The physician also stated that there were no other serious adverse reactions or injection site reactions. It was unknown if the patients recovered from the event. The causal relationship between the event and the therapy with ZOSTAVAX was not provided. Additional information has been requested.
Extreme fatique, exteme reaction to cold and or hot weather. Chronic pain in right hand finger and wrist. Overall Lupus like symptomes.  Diagnosed in July 2021 with Lupus and Rheumatoid
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient received GARDASIL (dose, lot# and route were not reported) outside of schedule. The first dose was received in April 2014; second dose in series was received on 21-DEC-2015. No adverse effects were reported. Additional information has been requested.
temperature went up to 98.2 Celsius.; like headache, body ache and flu; headache; body ache; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for herself. A female of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 09 Feb 2021, as a single dose for COVID-19 immunisation. The patient medical history included flu shot on 17Nov2020. Concomitant medications were not reported. After the first dose the patient experienced headache, body ache & flu she said her temperature went up to 98.2 Celsius. Patient scheduled for 2nd dose on 02Mar. At the time reporting, the outcome of the events were unknown.  No follow up attempts are possible. Information about lot/ batch number cannot be obtained.